Research finds retinal vessel leakage during high altitude exposure

At high altitude, marked bilateral leakage of peripheral retinal vessels was observed in 7 of 14 participants (50 percent). All findings completely reversed after descent. "Retinal capillary leakage should be considered a part of the spectrum of high-altitude retinopathy," the authors write.

"Exposure to high altitude can cause (AMS) and, in severe cases, cerebral or . Capillary leakage has been hypothesized to play a role in the of AMS, although the mechanism of altitude-related illnesses remains largely unknown," writes Gabriel Willmann, M.D., of the University of Tubingen, Germany, and colleagues. "Vessel leakage in the retinal periphery has not been investigated. Our objective was to assess retinal vessel integrity at high altitude using fluorescein angiography."

As reported in a Researcher Letter, the study included 14 healthy, unacclimatized volunteers (7 male and 7 female participants, average age, 35 years) who were studied at baseline (1,119 feet), after ascent to 14,957 feet within 24 hours, and more than 14 days after return by fluorescein angiography. Photographs were independently graded in random order by 4 for presence and location of leakage.

Retinal abnormalities were not noted at baseline in any of the participants. At high altitude, marked bilateral leakage of peripheral retinal vessels was observed in 7 of 14 participants (50 percent). All findings completely reversed after descent. "Retinal capillary leakage should be considered a part of the spectrum of high-altitude retinopathy," the authors write.

More information: JAMA. 2013;309[21]:2210-2212

Citation: Research finds retinal vessel leakage during high altitude exposure (2013, June 4) retrieved 23 April 2024 from https://medicalxpress.com/news/2013-06-retinal-vessel-leakage-high-altitude.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Monoclonal antibody effective therapy for diabetic retinopathy

 shares

Feedback to editors